In this issue:
INF activating therapy may synergise with chemotherapy in PTEN-deficient HGSOC
WEE1 inhibition promising for CCNE1-amplified EOC
Senaparib has anti-tumour activity in ovarian cancer
VIPER: NACT hinders visual evaluation of peritoneal disease
Adjuvant chemotherapy no benefit in stage 1A OCCC
Patient perspectives on RRSDO for ovarian cancer riskreduction
Completeness of surgery vital in ovarian sex cord-stromal tumours
Inferior outcomes in older women with EOC treated with chemotherapy
Please login below to download this issue (PDF)